Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2019
Mar 31, 2019
Dec 31, 2018
Sep 30, 2018
Total Revenue
133,841
172,794
193,718
155,054
Cost of Revenue
84,499
107,477
123,908
95,913
Gross Profit
49,342
65,317
69,810
59,141
Operating Expenses
Research Development
9,436
9,838
9,723
9,810
Selling General and Administrative
22,214
21,649
23,197
20,588
Non Recurring
--
--
--
--
Others
0
0
0
0
Total Operating Expenses
31,650
31,487
32,920
30,398
Operating Income or Loss
17,692
33,830
36,890
28,743
Income from Continuing Operations
Total Other Income/Expenses Net
(7,628)
(341)
(369)
(370,438)
Earnings Before Interest And Taxes
10,064
33,489
36,521
(341,695)
Interest Expense
20,194
21,485
21,512
21,433
Income Before Tax
(10,130)
12,004
15,009
(363,128)
Income Tax Expense
(2,544)
1,359
2,647
(75,600)
Minority Interest
--
--
--
--
Net Income From Continuing Ops
(7,586)
10,645
12,362
(287,528)
Non-recurring Events
Discontinued Operations
--
--
--
--
Extraordinary Items
--
--
--
--
Effect Of Accounting Changes
--
--
--
--
Other Items
0
0
0
0
Net Income
(7,586)
10,645
12,362
(287,528)
Preferred Stock And Other Adjustments
--
--
--
--
Net Income Applicable To Common Shares
(7,586)
10,645
12,362
(287,528)